TODAY'S HEADLINES

New diabetes drug enters competitive market

FDA just approved a new medication to treat type 2 diabetes. The drug enters a lucrative but competitive diabetes treatment market, which includes top-sellers such as Lantus, Januvia and Humalog. Read more

First 4-strain flu vaccine available

FDA recently approved the first 4-strain, cell culture-derived, inactivated seasonal flu vaccine available in the US. Flucelvax Quadrivalent influenza vaccine helps protect against the 2 influenza A viruses as well as 2 influenza B viruses. Read more

CONTINUING PHARMACY EDUCATION

Keep your patients moving: An overview of treatment options for constipation

This month's CE activity, "Keep your patient moving: An overview of treatment options for constipation," is open for pharmacists and pharmacy technicians.
The goal of this program is to assist pharmacists and pharmacy technicians in their understanding of the role of linaclotide, lubiprostone, methylnaltrexone, and naloxegol in the treatment of constipation after conventional nonpharmacologic interventions and conventional laxatives such as bulking agents, osmotic laxatives, and stimulant laxatives have failed.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

New treatment for kidney cancer gets OK

FDA recently approved lenvatinib (Lenvima, Eisai Inc.) in combination with everolimus for the treatment of advanced renal cell carcinoma. Read more

June 3, 2016

Related Articles

Major diabetes drug cuts heart attack risk

Visterra gets $29 million to develop novel flu drug